Biosafety of Mesoporous Silica Nanoparticles

Careful analysis of any new nanomedicine device or disposal should be undertaken to comprehensively characterize the new product before application, so that any unintended side effect is minimized. Because of the increasing number of nanotechnology-based drugs, we can anticipate that regulatory auth...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biomimetics (Basel)
Main Authors: Rascol, Estelle, Pisani, Cédric, Dorandeu, Christophe, Nyalosaso, Jeff L., Charnay, Clarence, Daurat, Morgane, Da Silva, Afitz, Devoisselle, Jean-Marie, Gaillard, Jean-Charles, Armengaud, Jean, Prat, Odette, Maynadier, Marie, Gary-Bobo, Magali, Garcia, Marcel, Chopineau, Joël, Guari, Yannick
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2018
Assuntos:
Perspective
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6352691/
https://ncbi.nlm.nih.gov/pubmed/31105244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomimetics3030022
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares